China’s Troxerutin prices showed signs of recovery in the first half of June as stronger downstream demand and improved buying interest supported a modest rebound in market sentiment. The decline recorded in May encouraged buyers from pharmaceutical, nutraceutical, and food-grade sectors to return to the market, helping absorb inventories and stabilize trading conditions. As a result, analysts expect Troxerutin prices to continue moving upward in the second half of June, supported by balanced supply and demand fundamentals. During May, the market faced pressure from increased domestic supply, fresh production capacity, and weak procurement activity from hospital formulators and export-oriented generic drug manufacturers. Additional inventories entered the market following regulatory approvals and facility restarts, intensifying competition among suppliers. However, steady feedstock availability and stable production costs helped maintain operational continuity. Looking ahead, improving demand from the pharmaceutical and nutraceutical industries, combined with normalized inventory levels and stable supply conditions, is expected to support further market strengthening. Freight-related uncertainties and export purchasing patterns will remain important factors influencing future market developments.
